Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors
Clinical trial NCT06658951 · RECRUITING
Trial details
- NCT number
- NCT06658951
- Sponsor
- UTC Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-03
- Primary completion
- 2027-04-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.